The Germany Endoscope Reprocessing Market was valued at $209.7 Million in 2025 and projected to reach to $374 Million by 2030, representing a compound annual growth rate of 12.3%. Germany's endoscope reprocessing market is positioned for sustained growth through 2030, driven by the country's commitment to infection prevention and control standards.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Germany's endoscope reprocessing market is valued at USD 209.7 million in 2025, with a projected expansion to USD 374.0 million by 2030, representing a robust 12.3% CAGR—significantly outpacing the global average of 9.4%.
Germany's stringent infection control regulations and adherence to EU medical device standards are propelling demand for advanced reprocessing technologies, ensuring hospitals maintain the highest sterilization and safety protocols.
Germany's well-established healthcare system with numerous hospitals and surgical centers is driving widespread adoption of automated and manual endoscope reprocessing solutions across medical facilities nationwide.
Increasing investment in advanced reprocessing technologies, including automated endoscope reprocessors and high-level disinfection systems, reflects Germany's commitment to modernizing surgical and diagnostic procedures.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | FLEXIBLE ENDOSCOPES (Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 9.4% from 2025 to 2030 |
| Largest Segment | HOSPITALS & ASCS (End User) |
| Market Size Base Year (Billions) | ~USD 2.71 (2025) |
| Revenue Forecast (Billions) | ~USD 4.24 (2030) |
| Segments Covered | Product, Type, Portability, Type Of Endoscope, End User |
5 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HOSPITALS & ASCS | 134.1 | 150.4 | 168.8 | 189.6 | 213.2 | 240 | 270.3 | 304.9 | 12.6 |
| OTHER END USERS | 10.7 | 11.8 | 13 | 14.3 | 15.8 | 17.5 | 19.3 | 21.4 | 10.5 |
| SPECIALTY CLINICS | 22.6 | 25.1 | 27.9 | 31 | 34.5 | 38.4 | 42.8 | 47.8 | 11.4 |
| TOTAL | 167.4 | 187.3 | 209.7 | 234.9 | 263.5 | 295.8 | 332.4 | 374 | 12.3 |
Germany's endoscope reprocessing market is valued at USD 209.7 million in 2025 and is projected to grow to USD 374.0 million by 2030.
Germany's endoscope reprocessing market is expected to grow at a CAGR of 12.3% from 2025 to 2030, outpacing the global average of 9.4%.
Growth in Germany is driven by stringent EU infection control regulations, increasing endoscopic procedure volumes, advanced healthcare infrastructure, and rising adoption of automated reprocessing systems.
Germany's 12.3% CAGR significantly exceeds the global market CAGR of 9.4%, indicating stronger regional demand and market maturity in infection control solutions.
Germany's endoscope reprocessing market is forecasted to reach USD 374.0 million by 2030, representing a 78.5% increase from the 2025 baseline.
The study involved key activities in estimating the current market size for the endoscope reprocessing market. Extensive secondary research was conducted to gather information on this sector. The next step was to validate these findings, assumptions, and size estimates with industry experts across the value chain through primary research. Different approaches, such as top-down and bottom-up methods, were used to calculate the total market size. Subsequently, market segmentation and data triangulation techniques were applied to estimate the size of various segments and subsegments within the endoscope reprocessing market.
The four steps involved in estimating the market size are:
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global endoscope reprocessing market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
During the primary research process for the endoscope reprocessing market, various stakeholders from both supply and demand sides were interviewed to gather qualitative and quantitative insights. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, product development managers, and heads of technology and innovation from leading companies offering endoscope reprocessing equipment, consumables, and tracking systems. On the demand side, respondents included infection control specialists, hospital procurement officers, sterilization technicians, and representatives from ambulatory surgical centers (ASCs), specialty clinics, and hospitals. The primary research aimed to validate the segmentation framework, identify key players and their strategies, and understand current and emerging trends, challenges, and market dynamics impacting the endoscope reprocessing industry.
The following is a breakdown of the primary respondents:
Note 1: Other designations include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were determined based on revenue mapping of leading product manufacturers and OEMs active in the worldwide endoscope reprocessing market. All key service providers were identified at the global, national, and/or national/regional levels. Revenue mapping for the respective business segments and sub-segments was conducted for the major players. The global endoscope reprocessing market was split into various segments and subsegments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
The research methodology used to estimate the market size includes the following:

After determining the overall market size using the process outlined above, the total market was divided into several segments. To complete the market engineering process and obtain precise data for all segments and subsegments, data triangulation and market breakdown methods were used wherever applicable. The data was triangulated by examining various factors and trends from both the demand and supply sides.
Endoscope reprocessing involves cleaning, high-level disinfection, or sterilization of reusable endoscopes to ensure safe reuse and prevent cross-contamination. The market includes automated reprocessing equipment (such as automated endoscope reprocessors (AER) and endoscope drying, storage, and transport systems), consumables (such as detergents, wipes, and disinfectants), and tracking systems that help maintain compliance with infection control standards. These solutions are essential for reducing healthcare-associated infections (HAIs) and are commonly used across hospitals, ambulatory surgical centers, and specialty settings clinics.
Full forecast, segment splits, and company analysis for all Endoscope Reprocessing Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report